Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLOV NASDAQ:RKLB NYSE:SB NYSE:SPCE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$2.94-2.3%$3.06$1.50▼$4.87$1.50B1.867.28 million shs7.31 million shsRKLBRocket Lab$51.39+0.1%$30.86$4.20▼$53.44$23.31B2.1518.80 million shs32.83 million shsSBSafe Bulkers$4.13$3.78$3.02▼$5.75$434.89M1.17568,871 shs458,196 shsSPCEVirgin Galactic$3.86+3.2%$3.23$2.18▼$8.19$160.50M2.092.70 million shs8.66 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments-0.33%-1.31%+6.36%-16.39%+75.00%RKLBRocket Lab+7.63%+31.28%+94.28%+160.03%+841.83%SBSafe Bulkers+2.47%+2.47%+8.08%+25.42%-26.77%SPCEVirgin Galactic+15.36%+22.91%+26.64%+48.71%-47.48%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLOVClover Health Investments1.9665 of 5 stars3.31.00.00.02.41.70.6RKLBRocket Lab2.7222 of 5 stars2.44.00.00.03.23.30.6SBSafe Bulkers3.6832 of 5 stars1.55.03.31.60.01.71.9SPCEVirgin Galactic1.9548 of 5 stars3.04.00.00.00.00.81.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLOVClover Health Investments 2.67Moderate Buy$4.8364.40% UpsideRKLBRocket Lab 2.75Moderate Buy$34.10-33.64% DownsideSBSafe Bulkers 3.00Buy$4.478.15% UpsideSPCEVirgin Galactic 2.00Hold$4.8124.68% UpsideCurrent Analyst Ratings BreakdownLatest SPCE, CLOV, RKLB, and SB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/16/2025RKLBRocket LabBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$30.00 ➝ $50.007/14/2025RKLBRocket LabCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$35.007/14/2025RKLBRocket LabCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$33.00 ➝ $50.007/2/2025RKLBRocket LabKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $40.006/30/2025RKLBRocket LabThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$27.006/30/2025SPCEVirgin GalacticThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$3.006/10/2025RKLBRocket LabCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $35.006/3/2025RKLBRocket LabKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight5/28/2025RKLBRocket LabRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$25.00 ➝ $35.005/28/2025RKLBRocket LabStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$29.00 ➝ $34.005/28/2025RKLBRocket LabNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$28.00 ➝ $32.00(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLOVClover Health Investments$1.37B1.09N/AN/A$0.68 per share4.32RKLBRocket Lab$436.21M53.43N/AN/A$0.76 per share67.62SBSafe Bulkers$307.63M1.41$1.36 per share3.03$7.79 per share0.53SPCEVirgin Galactic$7.04M22.80N/AN/A$9.77 per share0.40Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLOVClover Health Investments-$43.01M-$0.05N/AN/AN/A-1.69%-7.42%-4.00%8/5/2025 (Estimated)RKLBRocket Lab-$190.18M-$0.40N/AN/AN/A-44.32%-48.92%-17.28%8/7/2025 (Estimated)SBSafe Bulkers$97.38M$0.676.167.12N/A27.32%7.93%4.77%8/4/2025 (Estimated)SPCEVirgin Galactic-$346.74M-$11.93N/AN/AN/A-5,972.70%-97.17%-33.39%8/6/2025 (Estimated)Latest SPCE, CLOV, RKLB, and SB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025RKLBRocket Lab-$0.07N/AN/AN/AN/AN/A8/6/2025Q2 2025SPCEVirgin Galactic-$2.12N/AN/AN/A$0.45 millionN/A8/5/2025Q2 2025CLOVClover Health Investments$0.03N/AN/AN/A$468.30 millionN/A8/4/2025Q2 2025SBSafe Bulkers$0.09N/AN/AN/AN/AN/A5/19/2025Q1 2025SBSafe Bulkers$0.03$0.05+$0.02$0.05$57.92 million$64.35 million5/15/2025Q1 2025SPCEVirgin Galactic-$2.23-$2.38-$0.15-$2.38$0.33 million$0.46 million5/8/2025Q1 2025RKLBRocket Lab-$0.10-$0.12-$0.02-$0.12$120.74 million$122.57 million5/6/2025Q1 2025CLOVClover Health Investments-$0.07$0.05+$0.12N/A$466.93 million$462.33 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLOVClover Health InvestmentsN/AN/AN/AN/AN/ARKLBRocket LabN/AN/AN/AN/AN/ASBSafe Bulkers$0.204.84%N/A29.85%N/ASPCEVirgin GalacticN/AN/AN/AN/AN/ALatest SPCE, CLOV, RKLB, and SB DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/19/2025SBSafe Bulkersquarterly$0.055.36%6/6/20256/6/20256/20/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLOVClover Health InvestmentsN/A1.541.54RKLBRocket Lab0.972.081.72SBSafe Bulkers0.561.741.74SPCEVirgin Galactic1.553.813.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLOVClover Health Investments19.77%RKLBRocket Lab71.78%SBSafe Bulkers21.69%SPCEVirgin Galactic46.62%Insider OwnershipCompanyInsider OwnershipCLOVClover Health Investments24.07%RKLBRocket Lab13.70%SBSafe Bulkers40.25%SPCEVirgin Galactic0.27%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLOVClover Health Investments680508.92 million386.42 millionOptionableRKLBRocket Lab2,100453.55 million391.41 millionOptionableSBSafe Bulkers920105.30 million62.92 millionOptionableSPCEVirgin Galactic80041.58 million41.46 millionOptionableSPCE, CLOV, RKLB, and SB HeadlinesRecent News About These CompaniesWhy Space Tourism Is Closer Than You ThinkJuly 12, 2025 | imphaltimes.comIBollinger Shipyards converting barge into landing platform for returning rocketsJuly 12, 2025 | nola.comNAnalysts Offer Insights on Industrial Goods Companies: V2X (VVX) and Virgin Galactic Holdings (SPCE)July 2, 2025 | theglobeandmail.comHow to Buy Space Stocks ProfitablyJuly 1, 2025 | msn.comVirgin Galactic (NYSE:SPCE) Given "Neutral" Rating at The Goldman Sachs GroupJune 30, 2025 | marketbeat.comHow much does it cost to take a trip to outer space?June 28, 2025 | msn.comHighlights From When Virgin Galactic Unity Ascended To Space With 1st Pakistani AstronautJune 25, 2025 | msn.comWealthquest Corp Takes $1.34 Million Position in Virgin Galactic Holdings, Inc. (NYSE:SPCE)June 25, 2025 | marketbeat.comWhat Virgin Galactic's milestone flight means for the future of tourists in spaceJune 21, 2025 | nationalgeographic.comNVirgin Galactic Ramps Up For Delta Spaceplane Final AssemblyJune 18, 2025 | aviationweek.comANorah Patten set to boldly go where no one from Ireland has gone before - as the first Irish person in spaceJune 13, 2025 | msn.comVirgin Galactic Reports Inducement Award Under NYSE Listing Rule 303A.08June 12, 2025 | businesswire.comFormer Virgin Galactic GC Joins 'Blank Check' Company on Prowl for AcquisitionJune 10, 2025 | law.comLVirgin Galactic stock jumps on SpaceX competition speculationJune 7, 2025 | za.investing.comSpace Stocks Take Flight Premarket After Musk-Trump Rift Casts Doubt Over SpaceX ContractsJune 6, 2025 | msn.comVirgin Galactic Hldgs Stock Price, Quotes and Forecasts | NYSE:SPCE | BenzingaJune 5, 2025 | benzinga.comVirgin Galactic: Bleak Prospects, But A Glimmer Of HopeJune 5, 2025 | seekingalpha.comWho is Mark Rocket? The Christchurch entrepreneur who just became the first New Zealander in spaceJune 1, 2025 | msn.comVirgin Galactic Space Flight Tickets Increase to $600,000May 26, 2025 | ocbj.comOVirgin Galactic Holdings (NYSE:SPCE) Reports First-Quarter Earnings Decline With US$0.5 Million SalesMay 26, 2025 | finance.yahoo.comVirgin Galactic on track to start launching customers again in 2026, but seat prices will riseMay 23, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesThe Meteoric Rise of Rocket Lab: A Space Stock to WatchBy Ryan Hasson | July 11, 2025View The Meteoric Rise of Rocket Lab: A Space Stock to WatchRocket Lab: Latest Catalysts Bolster the Bull CaseBy Ryan Hasson | July 3, 2025View Rocket Lab: Latest Catalysts Bolster the Bull CaseRocket Lab Gets New Street-High Price Target from Citi By Ryan Hasson | July 16, 2025View Rocket Lab Gets New Street-High Price Target from Citi Cantor Boosts Rocket Lab Target to Street-High $35By Ryan Hasson | June 19, 2025View Cantor Boosts Rocket Lab Target to Street-High $35Rocket Lab: Europe Comes Calling as Momentum BuildsBy Ryan Hasson | June 27, 2025View Rocket Lab: Europe Comes Calling as Momentum BuildsSPCE, CLOV, RKLB, and SB Company DescriptionsClover Health Investments NASDAQ:CLOV$2.94 -0.07 (-2.33%) Closing price 04:00 PM EasternExtended Trading$2.95 +0.01 (+0.24%) As of 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.Rocket Lab NASDAQ:RKLB$51.39 +0.06 (+0.12%) Closing price 04:00 PM EasternExtended Trading$51.32 -0.07 (-0.14%) As of 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rocket Lab USA, Inc., a space company, provides launch services and space systems solutions for the space and defense industries. The company provides launch services, spacecraft design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions; and constellation management services, as well as designs and manufactures small and medium-class rockets. It also designs, manufactures, and sells Electron, a reusable orbital-class small rocket; and the Photon satellite platforms, as well as developing the Neutron 8-ton payload class launch vehicle; conducts remote launch activities; and designs and manufactures a range of components and subsystems for the Photon family of spacecraft and broader merchant spacecraft components. The company serves commercial, aerospace prime contractors, and government customers. Rocket Lab USA, Inc. was founded in 2006 and is headquartered in Long Beach, California.Safe Bulkers NYSE:SB$4.13 0.00 (0.00%) Closing price 03:59 PM EasternExtended Trading$4.12 -0.01 (-0.24%) As of 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Safe Bulkers, Inc., together with its subsidiaries, provides marine drybulk transportation services. It owns and operates drybulk vessels for transporting bulk cargoes primarily coal, grain, and iron ore. The company has a fleet of 47 drybulk vessels having an aggregate carrying capacity of 4,719,600 deadweight tons. Its fleet consists of 10 Panamax class vessels, 11 Kamsarmax class vessels, 18 post-Panamax class vessels, and 8 Capesize class vessels. Safe Bulkers, Inc. was incorporated in 2007 and is based in Monaco.Virgin Galactic NYSE:SPCE$3.86 +0.12 (+3.21%) Closing price 03:59 PM EasternExtended Trading$3.88 +0.02 (+0.52%) As of 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Virgin Galactic Holdings, Inc., an aerospace and space travel company, focuses on the development, manufacture, and operation of spaceships and related technologies. The company engages in the design and development, manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems for private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. is headquartered in Tustin, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.